Diabetes is a complex, multi-symptomatic disease whose complications drives increases in healthcare costs as the diabetes prevalence grows rapidly world-wide. Real-world electronic health records (EHRs) coupled with patient biospecimens, biological understanding, and technologies can characterize emerging diagnostic autoimmune markers resulting from proteomic discoveries.

A recent article published by Abbas et al. in the Journal of Biomedicine and Pharmacotherapy systematically revealed about the vaccines developed against the recent pandemic agents SARS-CoV-2 and its variants [1]. The authors insightfully provided an overview on the distinct features of the SARS-CoV-2 new variants, the associated mortality rate, hospitalization, re-infection and finally the efficacy of different vaccines.

India has an estimated population of 1.39199 billion and current vaccination approach plans to cover adult population (>18 y, about 67.53%) very soon. As on 24 December 2021, the country completed about 1.41 billion doses of COVID-19 vaccines, in about eleven months since the drive began.

Health Care worker (HCW) infection with corona virus disease 2019 (COVID-19) is a serious problem and there is a potential risk of mortality associated with it [1]. Such infection is generally attributed to transmission from patients with COVID-19 infection and there are now recommendations for best practices to limit such transmission.

Coronavirus Disease 2019 (COVID-19) currently has become a significant public health crisis and one of leading causes of death internationally. A considerable number of cases progresses to pneumonia with severe respiratory failure. So far, many studies address reduction of inpatient mortality and containment of the spread of infection. Nevertheless, most infected people develop smooth symptoms and are treated ambulatory.